19 May 2013
Keywords: imutec, restarts, virulizin, program, corp, shortly, restart
Article | 08 April 1996
Imutec Corp will shortly restart its clinical trial program for
Virulizin for the treatment of advanced Kaposi's sarcoma in patients
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
17 May 2013
© 2013 thepharmaletter.com